Figure 3 | Experimental & Molecular Medicine

Figure 3

From: ANT2 shRNA downregulates miR-19a and miR-96 through the PI3K/Akt pathway and suppresses tumor growth in hepatocellular carcinoma cells

Figure 3

Overexpression of miR-96 contributes to the progression of hepatocellular carcinoma (HCC). (a) Negative control (NC)- or miR-96-transfected HepG2 cells (1 × 106) were injected subcutaneously into each posterior flank of the mice (n=4). Tumor sizes were measured by a caliper. The mean±s.d. is shown, and data were evaluated using Student’s t-test. (b) Images of representative features of tumors 88 days after inoculation.

Back to article page